Showing results 7 to 7 of 7
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial Journal:The Lancet Gastroenterology & Hepatology | 2020 | 31 |